Share to Facebook Share to Twitter Share to Linkedin Sausages produced with Cellva's cultivated pork fat Juan Gasparin Fotografia As industries increasingly turn to synthetic sources that mimic real components for product development, the Brazilian biotechnology firm Cellva is attracting investor interest with its approach to cultivated animal fat and bioingredients. The São Paulo-based company has developed a process to grow pork fat in a lab environment without the need to slaughter animals, using advanced bioreactors to multiply fat cells extracted from a living pig. The lab-grown fat provides fatty acids like omega-3 and omega-9, while also offering an alternative to traditional animal fat in food products.
Beyond fat cultivation, Cellva also develops microcarriers and microcapsules. These platforms provide protection and controlled release of active ingredients and can be applied not only in the food industry but also in pharmaceuticals and beauty products. To broaden its reach and expand the commercialization of its patented products to new markets, the company recently raised a seed round of BRL 8.
5 million ($1.5 million), attracting a mix of Brazilian and international investors such as Fundepar, Proveg, Rumbo, AirCapital, and EA Angels. Additionally, a pool of 151 individual investors led by the equity crowdfunding firm Captable also joined the round, representing 10% of the total amount raised.
“We aim to target the high-value nutraceuticals market and provide m.